Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.
Year: 1990
Type: article
Source: PubMed
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2406278166
